The AKT/FSCN1 lesions display enhanced proliferation as gauged by EdU incorporation, they exhibited cholangiocellular features based on the immunoreactivity for the CK19 and A6 markers, and histopathologic analyses indicated them as neoductular proliferation or cholangiomas (Fig. 3e, f). Here, AKT1 is linked to bile duct adenoma.